| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Accounting Officer | Chief Financial Officer
1 company
Hunt Jonathan Robert serves as a Chief Accounting Officer at CATX. Across recent SEC filings that breaks down to 14 buys and 0 sells. Those positions are worth an estimated $121K at current prices.
Historically, Hunt Jonathan Robert's trades have earned a middling insider score of 61/100 across 9 rated trades. Over a 12-month horizon, 37.5% of those trades were profitable, with an average 12-month return of -5.8%.
The biggest single holding is CATX (~$121K) as Chief Accounting Officer. Net of sales, the recent Form 4 record there shows accumulation of 367,345 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 13, 2025 | CATX Perspective Therapeutics, Inc. | Chief Accounting Officer | Buy | 11,000 | $2.03 | $22,294.80 | +22.5% | +135.7% | - | |
| Nov 25, 2024 | CATX Perspective Therapeutics, Inc. | Chief Financial Officer | Buy | 12,829 | $3.82 | $48,974.26 | +35.7% | -26.0% | -40.7% | |
| Jun 17, 2024 | CATX Perspective Therapeutics, Inc. | Chief Financial Officer | Buy | 1,800 | $9.82 | $17,667.00 | +5.3% | +26.9% | -65.9% | |
| May 31, 2024 | CATX Perspective Therapeutics, Inc. | Chief Financial Officer | Buy | 25,006 | $1.40 | $35,007.10 | +7.9% | +12.9% | -81.4% | |
| Dec 18, 2023 | CATX Perspective Therapeutics, Inc. | Chief Financial Officer | Buy | 125,000 | $0.26 | $32,337.50 | +65.2% | +272.6% | +18.5% | |
| Dec 5, 2022 | CATX Perspective Therapeutics, Inc. | Chief Financial Officer | Buy | 85,404 | $0.38 | $32,501.40 | +80.3% | +27.4% | -23.1% | |
| Jun 8, 2022 | CATX Perspective Therapeutics, Inc. | Chief Financial Officer | Buy | 39,000 | $0.29 | $11,160.86 | +57.9% | +18.1% | +83.7% | |
| Oct 22, 2020 | CATX Perspective Therapeutics, Inc. | Chief Financial Officer | Buy | 67,306 | $0.52 | $34,999.12 | New | - | - |